Ainos Inc. (AIMD)
0.68
0.10 (17.22%)
At close: Jan 14, 2025, 3:59 PM
0.67
-1.02%
After-hours Jan 14, 2025, 07:57 PM EST
undefined% (undefined)
| Bid | 0.65 |
| Market Cap | 9.57M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.71 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.7 |
| Volume | 1,187,462 |
| Avg. Volume (20D) | 582,098 |
| Open | 0.59 |
| Previous Close | 0.58 |
| Day's Range | 0.58 - 0.77 |
| 52-Week Range | 0.40 - 3.10 |
| Beta | undefined |
About AIMD
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 8, 2021
Employees 46
Stock Exchange NASDAQ
Ticker Symbol AIMD
Website https://ainos.com
5 months ago ·
Source
+8.06%
Ainos shares are trading higher after the company ...
Unlock content with
Pro Subscription
5 months ago ·
Source
+1.2%
Ainos shares are trading higher after the company announced that it has obtained exclusive licenses for a total of 10 invention patents and patent applications from Taiwan Carbon Nano Technology.
